- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Financially Fit Penny Stocks
U.S. Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
213
8 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
213 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
KPRX | US$3.30 | -1.5% | -33.9% | US$9.9m | US$30.33 | PE1.8x | E20.7% | n/a | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
PBYI | US$3.05 | -3.2% | -28.9% | US$149.7m | US$4.33 | PE6.4x | E-47.6% | n/a | ||
BFRI | US$1.09 | 1.9% | -64.3% | US$8.4m | US$11.50 | PS0.2x | E61.3% | n/a | ||
GNLX | US$2.36 | -4.1% | -82.9% | US$80.5m | US$18.40 | PS10060.9x | E34.0% | n/a | ||
EVAX | US$0.85 | -0.07% | -89.0% | US$4.7m | US$11.56 | PS1.4x | E53.5% | n/a | ||
UNCY | US$0.79 | 0.6% | -4.3% | US$82.4m | US$5.50 | PB3x | E41.1% | n/a | ||
ALDX | US$4.99 | -0.6% | 49.4% | US$297.2m | US$10.00 | PB3.5x | E59.9% | n/a | ||
VNDA | US$4.79 | -0.4% | 13.2% | US$279.3m | US$12.17 | PS1.5x | E95.9% | n/a | ||
EVOK New | US$4.42 | -9.6% | -64.2% | US$9.1m | US$18.00 | PS1.1x | E124.7% | n/a | ||
PGEN | US$1.12 | 51.6% | -14.5% | US$328.0m | US$5.33 | PS82.8x | E57.5% | n/a | ||
SKYE | US$2.83 | 6.4% | 9.3% | US$85.9m | US$18.00 | PB1.1x | E-31.8% | n/a | ||
PLX | US$1.88 | 5.6% | 8.0% | US$138.4m | US$14.00 | PS3x | E118.3% | n/a | ||
EPIX | US$1.79 | 11.2% | -71.0% | US$79.5m | US$9.50 | PB0.6x | E45.9% | n/a | ||
VYNE | US$3.35 | 3.7% | 55.1% | US$49.4m | US$6.19 | PS100.2x | E-18.2% | n/a | ||
SAVA | US$2.36 | -8.9% | -89.9% | US$113.5m | n/a | PB0.7x | E58.3% | n/a | ||
CLRB | US$0.30 | -2.5% | -89.4% | US$12.3m | US$5.67 | PB8x | E16.4% | n/a | ||
SGMT | US$4.50 | -11.4% | -10.7% | US$144.9m | US$29.14 | PB0.8x | E-18.5% | n/a | ||
GRCE | US$3.74 | 1.1% | 38.0% | US$37.9m | US$10.60 | PB0.7x | E48.1% | n/a | ||
XLO | US$0.95 | -2.1% | 31.8% | US$42.0m | US$4.50 | PS9.1x | E-27.6% | n/a | ||
ATYR | US$3.62 | -4.0% | 139.7% | US$303.9m | US$21.29 | PS1293.1x | E59.6% | n/a | ||
ACIU | US$2.70 | -0.2% | -39.1% | US$267.1m | US$10.20 | PS5.9x | E47.5% | n/a | ||
ADAG | US$1.99 | 1.5% | -5.2% | US$88.1m | US$8.03 | PS108x | E12.3% | n/a | ||
PRPH | US$0.76 | 20.9% | -84.3% | US$18.1m | US$18.50 | PS1.4x | E77.4% | 0% |